Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect?
COVID-19
Diagnosis delay
Head and neck cancer
Lockdown
Oncology
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
11
02
2021
accepted:
17
04
2021
pubmed:
1
5
2021
medline:
1
2
2022
entrez:
30
4
2021
Statut:
ppublish
Résumé
Since the spreading of SARS-CoV-2 from China, all deferrable medical activities have been suspended, to redirect resources for the management of COVID patients. The goal of this retrospective study was to investigate the impact of COVID-19 on head and neck cancers' diagnosis in our Academic Hospital. A retrospective analysis of patients treated for head and neck cancers between March 12 and November 1, 2020 was carried out, and we compared these data with the diagnoses of the same periods of the 5 previous years. 47 patients were included in this study. We observed a significative reduction in comparison with the same period of the previous 5 years. Our findings suggest that the COVID-19 pandemic is associated with a decrease in the number of new H&N cancers diagnoses, and a substantial diagnostic delay can be attributable to COVID-19 control measures.
Sections du résumé
BACKGROUND
BACKGROUND
Since the spreading of SARS-CoV-2 from China, all deferrable medical activities have been suspended, to redirect resources for the management of COVID patients. The goal of this retrospective study was to investigate the impact of COVID-19 on head and neck cancers' diagnosis in our Academic Hospital.
METHODS
METHODS
A retrospective analysis of patients treated for head and neck cancers between March 12 and November 1, 2020 was carried out, and we compared these data with the diagnoses of the same periods of the 5 previous years.
RESULTS
RESULTS
47 patients were included in this study. We observed a significative reduction in comparison with the same period of the previous 5 years.
CONCLUSIONS
CONCLUSIONS
Our findings suggest that the COVID-19 pandemic is associated with a decrease in the number of new H&N cancers diagnoses, and a substantial diagnostic delay can be attributable to COVID-19 control measures.
Identifiants
pubmed: 33929609
doi: 10.1007/s00405-021-06834-1
pii: 10.1007/s00405-021-06834-1
pmc: PMC8085654
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
961-965Informations de copyright
© 2021. The Author(s).
Références
Sci Total Environ. 2021 Jan 1;750:141711
pubmed: 32835962
Ear Nose Throat J. 2020 Dec;99(10):625-626
pubmed: 32633654
Cancer Manag Res. 2020 May 25;12:3859-3864
pubmed: 32547222
Transl Med UniSa. 2020 Dec 31;23:42-47
pubmed: 33457322
Eur Arch Otorhinolaryngol. 2020 Jul;277(7):2151-2153
pubmed: 32377857
Disaster Med Public Health Prep. 2021 Aug;15(4):e8-e9
pubmed: 32907670
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Cancers (Basel). 2021 Jan 22;13(3):
pubmed: 33499223
EClinicalMedicine. 2020 Aug;25:100464
pubmed: 32838237
Ear Nose Throat J. 2020 Nov;99(9):563-564
pubmed: 32419495
Lancet Oncol. 2020 Aug;21(8):1000-1002
pubmed: 32702312
Pediatr Blood Cancer. 2020 Oct;67(10):e28640
pubmed: 32761998
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
Transl Med UniSa. 2020 Dec 31;23:37-38
pubmed: 33457320
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310